News tagged ‘Melanoma’ clear
- One of the shortcomings of a therapy that uses millions of
identical antibodies to boost the immune system's attack on cancer cells
is that many patients whose tumors recede in response to the treatment
also experience serious inflammatory problems, such as severe diarrhea
and rashes. In a new study, a team led by Dana-Farber Cancer Institute
researchers shows that giving periodic infusions of such "monoclonal"
antibodies to patients who have received a widely used cancer vaccine
unleashes a strong immune response to tumors, with less-harsh side
Tags: Melanoma, OvarianCancer, TargetedTherapy
- Dana-Farber researchers are studying melanoma tumors' microenvironments to better understand how some melanoma continue to grow and survive despite the presence of anti-cancer drugs.
Tags: BasicResearch, Genomics, Melanoma
- It's still possible to get too much sun exposure in winter. Dana-Farber's skin cancer specialists explain the dangers and offer sun safety tips to help you protect your skin while enjoying outdoor winter activities.
Tags: Melanoma, Prevention, SkinCancer
- As the weather grows warmer, Dana-Farber Cancer Institute physicians and nurses are encouraging people to be aware of the dangers of overexposure to the sun and to practice sun safety
Tags: Melanoma, Prevention
- Dana-Farber Cancer Institute researchers have developed a powerful
method for charting the positions of key gene-regulating molecules
called nucleosomes throughout the human genome.
Tags: Genomics, Melanoma
- ABC News' Sam Donaldson shared his experience as a melanoma patient during his keynote speech at the Dana-Farber Cancer Institute Joint Visiting Committee Symposium dinner Nov. 15.
- Dana-Farber and Broad Institute researchers have identified two mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date.
Tags: Genomics, Melanoma
- In a demonstration that even some of the most hard-to-treat
tumors may one day succumb to therapies aimed at molecular "weak
points," researchers at Dana-Farber report the first instance in which
metastatic melanoma has been driven into remission by a targeted
Tags: Melanoma, TargetedTherapy
- A clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.
Tags: ImmuneSystem, Melanoma